Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,174
Closed -$221K 217
2025
Q4
$221K Buy
1,174
+99
+9% +$18.6K 0.03% 216
2025
Q3
$221K Sell
1,075
-59
-5% -$12.6K 0.03% 212
2025
Q2
$253K Buy
1,134
+90
+9% +$19.4K 0.04% 187
2025
Q1
$215K Buy
+1,044
New +$208K 0.04% 197
2024
Q4
Sell
-1,010
Closed -$208K 223
2024
Q3
$208K Buy
+1,010
New +$195K 0.04% 198
2022
Q4
Sell
-2,256
Closed -$219K 180
2022
Q3
$219K Buy
+2,256
New +$230K 0.06% 126

Other funds holding CTAS

CFO4Life Group's CTAS Position: Q1 2026 in Review

CFO4Life Group sold out of Cintas (CTAS) in Q1 2026, closing a stake of 1,174 shares — an estimated $221K sold.

CFO4Life Group first reported a position in CTAS in Q3 2022 and held it in 6 quarters. The position peaked at $253K in Q2 2025. 1,429 funds tracked by Wall St. Rank hold CTAS as of Q1 2026.

  • CFO4Life Group reported no remaining Cintas position as of Q1 2026 after selling out during the quarter.
  • CFO4Life Group sold 1,174 Cintas shares in Q1 2026, an estimated $221K.
  • CFO4Life Group first reported a position in Cintas in Q3 2022 and held it in 6 quarters.
  • CFO4Life Group's Cintas position peaked at $253K in Q2 2025.
  • 1,429 funds tracked by Wall St. Rank held Cintas as of Q1 2026.

Based on CFO4Life Group's 13F filing for Q1 2026, filed 11 May 2026.